The effect of the HBsAg on foetal development has not been assessed. However, as with all inactivated viral vaccines, the risks to the foetus are considered to be negligible. Euvax-B should be used during pregnancy only when clearly needed.
The effect on breast-fed infants of the administration of Euvax-B to their mothers has not been evaluated in clinical studies. No contraindication has been established.